General Gastro News Articles

Gastro

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Furuta T et al. – In GI–tract cancer chemotherapy, 5–FU, gemcitabine, taxanes (docetaxel and paclitaxel), platinum (cisplatin and oxaliplatin) and irinotecan are often used, and molecular targeting therapy has also been developed. The respective PGx markers to such agents have been reported. Of the candidate PGx markers, K–ras mutation and UGT1A1 polymorphisms have sufficient evidence to justify routine clinical assessment for the selection of anti–cancer regimens.

Related Articles

Metastatic breast cancer mimicking primary depressed gastric cancer
Gastrointestinal Endoscopy, 10/22/09    Relevance Score: 81%

Socioeconomic factors associated with risk of upper aerodigestive tract cancer in Europe
European Journal of Cancer, 10/29/09    Relevance Score: 79%

EGFR and HER2 expression in advanced biliary tract cancer
World Journal of Gastroenterology, 10/06/09    Relevance Score: 79%

Usefulness of a second endoscopic arm to improve therapeutic endoscopy in the lower gastrointestinal tract. Preliminary experience - a case series
Endoscopy, 10/30/09    Relevance Score: 78%

Impact of postoperative irradiation after non-curative resection of hilar biliary cancer
Journal of Surgical Oncology, 10/09/09    Relevance Score: 78%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address